Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Biomedicines|September 27, 2025
Allogeneic NKG2D CAR-T Cell Therapy: A Promising Approach for Treating Solid TumorsSabir A Mukhametshin, Elvina M Gilyazova, Damir R Davletshin, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 19, 2025
Highlighting recent achievements to advance more effective cancer immunotherapyBeatrice Belmonte, Sheila Spada, Paola Allavena, et al.
Advanced Healthcare Materials|February 12, 2026
Patient-Derived 3D Bioprinted Cardiac Organoid Constructs Reveal Key Pathological Features of Duchenne Muscular DystrophyVittoria Marini, Margalida Campaner Socias, Andreas Dimopoulos, et al.
Cancers|March 13, 2024
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in RhabdomyosarcomaSilvia Codenotti, Leonardo Sandrini, Delia Mandracchia, et al.
Cell Death & Disease|July 7, 2026
Unraveling the dual roles of MICAL2 in skeletal muscle physiology and fusion negative rhabdomyosarcoma tumor progressionAshley Wang, Nefele Giarratana, Simen Cassiman, et al.
EMBO Reports|September 10, 2020
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperationRoberta Melchionna, Sheila Spada, Francesca Di Modugno, et al.
Oncogene|June 17, 2018
hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axisFrancesca Di Modugno, Sheila Spada, Belinda Palermo, et al.
Cell Reports|January 12, 2025
miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcomaEnrico Pozzo, Laura Yedigaryan, Nefele Giarratana, et al.
Communications Biology|February 27, 2020
Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigensAlessio Grimaldi, Ilenia Cammarata, Carmela Martire, et al.
Pageof 5